BioCentury | May 8, 2006
Company News

Bioniche, RoundTable Health Partners deal

...BNC sold its Cystistat sodium hyaluronate solution to former subsidiary Bioniche Pharma Group Ltd. (County Galway...
...subsidiary Bioniche Pharma Group Ltd. (County Galway, Ireland) for C$10 million ($8.2 million) in cash. Cystistat...
BioCentury | Nov 7, 2005
Company News

Bioniche, RoundTable Healthcare Partners deal

...sold its Bioniche Pharma Group to RoundTable for an undisclosed sum. The deal excludes BNC's Cystistat...
BioCentury | Apr 25, 2005
Clinical News

Cystistat genitourinary data

...In a Spanish study in 71 patients, 14% of patients receiving weekly intravesical Cystistat plus usual...
...Microbiology and Infectious Diseases meeting in Ottawa. Bioniche Life Sciences Inc. (TSE:BNC), Belleville, Ontario Product: Cystistat...
BioCentury | Apr 25, 2005
Clinical News

Cystistat genitourinary data

...Data from a Greek study in 40 women showed that 70% of women treated with Cystistat...
...Infectious Diseases meeting in Ottawa. Bioniche Life Sciences Inc. (TSE:BNC), Belleville, Ontario Business: Genitourinary Product: Cystistat...
BioCentury | Aug 25, 2003
Clinical News

Cystistat sodium hyaluronate: Marketed in EU and Canada

...the response rate for Cystistat was not statistically different from placebo. While >50% of the Cystistat-treated...
...the primary endpoint of response, BNC said the placebo response rate was larger than expected. Cystistat...
...interstitial cystitis, radiation-induced cystitis and other indications. Bioniche Life Sciences Inc. (TSE:BNC), Belleville, Ontario Product: Cystistat...
BioCentury | Mar 19, 2001
Company News

Bioniche, Laboratoire Thea sales and marketing update

...Thea will exclusively distribute in France BNC's Cystistat purified hyaluronan to treat interstitial cystitis. Bioniche Life...
BioCentury | Mar 12, 2001
Company News

Bioniche, UroCor sales and marketing update

...BNC granted UCOR exclusive U.S. distribution rights to its Cystistat hyaluronic acid derivative for cystitis in...
...$2.3 million in milestone payments. The companies will work together to obtain U.S. approval of Cystistat...
BioCentury | Mar 7, 2001
Company News

UroCor, Bioniche urology deal

...Bioniche (TSE:BNC) granted UCOR exclusive U.S. distribution rights to its Cystistat hyaluronic acid derivative for cystitis...
BioCentury | Oct 9, 2000
Company News

Bioniche, Cytochemia AG sales and marketing update

...Cytochemia will exclusively distribute in Germany BNC's Cystistat purified hyaluronic acid derivative. The product, which is...
BioCentury | Sep 11, 2000
Clinical News

Cystistat purified hyaluronic acid derivative regulatory update

...BNC received European marketing approval for Cystistat to treat radiation cystitis and cystitis caused by infections...
...treat radiation cystitis and cystitis caused by infections, trauma, urolithiasis, urinary retention and neoplasia. Previously, Cystistat...
...approved in Canada for the broader indication. Bioniche Life Sciences Inc. (TSE:BNC), London, Ontario Product: Cystistat...
Items per page:
1 - 10 of 23